The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

BMC Cancer

Table 5 Immunotherapy Trials

Immunotherapy	Trials (n)	%
Immune checkpoint inhibitors	17	51.5
Vaccine	7	21.2
Adoptive cell transfer	5	15.2
Immunomodulator^a	2	6.1
Oncolytic virus	2	6.1

^aImmunomodulators are the active agents of immunotherapy. They are a diverse array of recombinant, synthetic, and natural preparations including interleukins, cytokines, chemokines

ISSN: 1471-2407